Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 October 2004, Vol. 104, No. 7, pp. 2095-2101.
Prepublished online as a Blood First Edition Paper on June 3, 2004; DOI 10.1182/blood-2004-02-0584.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
2004-02-0584v1
104/7/2095    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FIESCHI, C.
Right arrow Articles by CASANOVA, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FIESCHI, C.
Right arrow Articles by CASANOVA, J.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted February 23, 2004
Accepted May 3, 2004

A novel form of complete IL-12/IL-23 receptor {beta}1-deficiency with cell surface-expressed non-functional receptors

Claire FIESCHI, Marita BOSTICARDO, Ludovic DE BEAUCOUDREY, Stephanie BOISSON-DUPUIS, Jacqueline FEINBERG, Orchidee FILIPE SANTOS, Jacinta BUSTAMANTE, Jacov LEVY, Fabio CANDOTTI, and Jean-Laurent CASANOVA*

INSERM U550, Necker Medical School, Paris, France
Disorders of Immunity Section, NIH, Bethesda, MD, USA
Division of Pediatrics, Ben Gourion University, Beer Sheva, Israel
INSERM U550, Necker Medical School, Paris, France; Pediatric Immunology and hematology Unit, Necker Hospital, Paris, France

* Corresponding author; email: casanova{at}necker.fr.

Complete interleukin-12/interleukin-23 receptor {beta}1 (IL-12R{beta}1) deficiency is the most frequent known genetic etiology of the syndrome of Mendelian susceptibility to mycobacterial disease. The patients described to date lack IL-12R{beta}1 at the surface of their NK and T cells due to IL12RB1 mutations, which either interrupt the open reading frame or disrupt protein folding. We describe a patient with a large in-frame deletion of 12,165 nucleotides in IL12RB1, encompassing exons 8 to 13 and resulting in the surface expression of non-functional IL-12R{beta}1. These six exons encode the proximal NH2-terminal half of the extracellular domain downstream from the cytokine binding domain. Five of six monoclonal anti-IL-12R{beta}1 antibodies tested recognized the internally truncated chain on the cell surface. However, IL-12 and IL-23 did not bind normally to the patient's IL-12R{beta}1-containing respective heterodimeric receptors. As a result, STAT-4 was not phosphorylated and IFN{gamma} production was not induced in the patient's cells upon stimulation with even high doses of IL-12 or IL-23. The functional defect was completely rescued by retrovirus-mediated IL-12R{beta}1 gene transfer. Thus, the detection of IL-12R{beta}1 on the cell surface does not exclude the possibility of complete IL-12R{beta}1 deficiency in patients with mycobacteriosis or salmonellosis. Paradoxically, the largest IL12RB1 mutation detected is associated with the cell surface expression of non-functional IL-12R{beta}1, defining a novel genetic form of IL-12R{beta}1 deficiency.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
S Y Patel, R Doffinger, G Barcenas-Morales, and D S Kumararatne
Genetically determined susceptibility to mycobacterial infection
J. Clin. Pathol., September 1, 2008; 61(9): 1006 - 1012.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. A. Khader, S. Partida-Sanchez, G. Bell, D. M. Jelley-Gibbs, S. Swain, J. E. Pearl, N. Ghilardi, F. J. deSauvage, F. E. Lund, and A. M. Cooper
Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection
J. Exp. Med., July 10, 2006; 203(7): 1805 - 1815.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
O. Filipe-Santos, J. Bustamante, M. H. Haverkamp, E. Vinolo, C.-L. Ku, A. Puel, D. M. Frucht, K. Christel, H. von Bernuth, E. Jouanguy, et al.
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production
J. Exp. Med., July 10, 2006; 203(7): 1745 - 1759.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Chapgier, R. F. Wynn, E. Jouanguy, O. Filipe-Santos, S. Zhang, J. Feinberg, K. Hawkins, J.-L. Casanova, and P. D. Arkwright
Human Complete Stat-1 Deficiency Is Associated with Defective Type I and II IFN Responses In Vitro but Immunity to Some Low Virulence Viruses In Vivo.
J. Immunol., April 15, 2006; 176(8): 5078 - 5083.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020